Determination of Dosing and Frequency of BCG Administration to Alter T-Lymphocyte Profiles in Type I Diabetics - Contacts and Locations

Determination of Dosing and Frequency of BCG Administration to Alter T-Lymphocyte Profiles in Type I Diabetics

This study is currently recruiting participants.
Information provided by Massachusetts General Hospital

Please refer to this study by its ClinicalTrials.gov identifier: NCT00607230

Contacts


Contact: Richard Pompei, RN BSN	617-726-2141	rpompei@partners.org

Locations


United States, Massachusetts
	Diabetes Research Center at Massachusetts General Hospital	Recruiting
	Boston, Massachusetts, United States, 02114
	Contact: Richard Pompei, RN, BSN 617-726-2141 rpompei@partners.org
	Contact: Richard Pompei, RN, BSN 617-726-1847 rpompei@partners.org
	Principal Investigator: David M Nathan, MD

Sponsors and Collaborators

Massachusetts General Hospital

Iacocca Foundation

Investigators


Principal Investigator:	David M Nathan, MD	Massachusetts General Hospital, Harvard Medical School